Mozavaptan

Mozavaptan Struktur
137975-06-5
CAS-Nr.
137975-06-5
Englisch Name:
Mozavaptan
Synonyma:
CS-134;OPC31260l;OPC 31260;MOZAVAPTAN;Mozavaptan USP/EP/BP;Mozavaptan (OPC-31260);N-(4-(5-(Dimethylamino);OPC-31260; OPC31260L; OPC 31260;-2,3,4,5-tetrahydro-1H-benzo[b]azepine-1-carbonyl);5-(Dimethylamino)-1-[4-(2-methylbenzamido)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine
CBNumber:
CB51388577
Summenformel:
C27H29N3O2
Molgewicht:
427.54
MOL-Datei:
137975-06-5.mol

Mozavaptan Eigenschaften

Schmelzpunkt:
213 - 217°C
Siedepunkt:
543.0±50.0 °C(Predicted)
Dichte
1.21±0.1 g/cm3(Predicted)
storage temp. 
Sealed in dry,Room Temperature
Löslichkeit
Chloroform (Slightly), DMSO (Slightly), Methanol (Slightly)
Aggregatzustand
Solid
pka
13.04±0.70(Predicted)
Farbe
White to Off-White

Sicherheit

Mozavaptan Chemische Eigenschaften,Einsatz,Produktion Methoden

Beschreibung

Mozavaptan is an oral vasopressin V2 antagonist that has been launched in Japan for inappropriate antidiuretic hormone secretion syndrome (IADHS), an affliction manifesting as hyponatremia. It joins another nonpeptidic benzazepine, conivaptan, which corrects sodium and water imbalance by blocking the renal V2 receptor resulting in enhanced diuresis, thereby effectively increasing serum sodium concentration. While conivaptan inhibits both V1 and V2 receptors, mozavaptan is significantly more selective for V2 (IC50 of 14nM vs. 1.2 mM for V1).

Verwenden

Mozavaptan is a vasopressin-receptor antagonist. It is used in the treatment of congestive heart failure and hyponatremia.

Mozavaptan Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


Mozavaptan Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 135)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Hebei Mojin Biotechnology Co., Ltd
+8613288715578
sales@hbmojin.com China 12457 58
career henan chemical co
+86-0371-86658258
sales@coreychem.com China 29914 58
Hubei Jusheng Technology Co.,Ltd.
18871490254
linda@hubeijusheng.com CHINA 28180 58
Hebei Guanlang Biotechnology Co., Ltd.
+86-19930503282
alice@crovellbio.com China 8823 58
Xiamen AmoyChem Co., Ltd
+86-592-6051114 +8618959220845
sales@amoychem.com China 6387 58
BOC Sciences
+1-631-485-4226
inquiry@bocsci.com United States 19553 58
Chongqing Chemdad Co., Ltd
+86-023-61398051 +8613650506873
sales@chemdad.com China 39916 58
CONIER CHEM AND PHARMA LIMITED
+8618523575427
sales@conier.com China 47465 58
Neostar United (Changzhou) Industrial Co., Ltd.
+86-519-519-85557386
marketing1@neostarunited.com China 8349 58
SIMAGCHEM CORP
+86-13806087780
sale@simagchem.com China 17367 58

137975-06-5()Verwandte Suche:


  • OPC 31260
  • MOZAVAPTAN
  • 5-(Dimethylamino)-1-[4-(2-methylbenzamido)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine
  • Benzamide, N-[4-[[5-(dimethylamino)-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl]carbonyl]phenyl]-2-methyl-
  • -2,3,4,5-tetrahydro-1H-benzo[b]azepine-1-carbonyl)
  • N-(4-(5-(Dimethylamino)
  • CS-134
  • OPC-31260; OPC31260L; OPC 31260
  • OPC31260l
  • N-[4-[[5-(dimethylamino)-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl]carbonyl]phenyl]-2-methyl-
  • Mozavaptan USP/EP/BP
  • N-[4-[5-(dimethylamino)-2,3,4,5-tetrahydro-1-benzazepine-1-carbonyl]phenyl]-2-methylbenzamide
  • N-(4-(5-(Dimethylamino)-2,3,4,5-tetrahydro-1H-benzo[b]azepine-1-carbonyl)phenyl)-2-methylbenzamide
  • Mozavaptan (OPC-31260)
  • 137975-06-5
  • Inhibitors
  • Pharmaceutical intermediate
Copyright 2019 © ChemicalBook. All rights reserved